Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.50
Delayed Data
As of Sep 30
 +0.18 / +13.64%
Today’s Change
1.01
Today|||52-Week Range
5.85
-61.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues1.9M843.0K0.00150.0K
 
 
 
 
Depreciation And Amortization210.0K133.0K32.0K29.0K
 
 
 
 
 
 
Operating ExpensesGross Income-----32.0K--
 
 
General Expenses17.9M14.9M9.5M9.7M
 
 
 
 
 
Research And Development12.2M9.3M4.2M4.3M
 
 
 
 
 
Total Operating Expenses18.1M15.0M9.5M9.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.2M-14.2M-9.5M-9.5M
 
 
 
 
 
Extraordinary Charge-51.0K0.000.000.00
 
 
Other Expenses-274.0K339.0K910.0K592.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-16.5M-13.8M-8.5M-8.6M
 
 
 
 
 
Income Taxes-2.1M-2.0M-993.0K-1.3M
 
 
 
 
 
Preferred Dividend-201.0K-200.0K-7.4M-201.0K
 
 
 
 
 
Net Income-14.3M-11.8M-7.5M-7.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS2.7M3.4M7.6M12.1M
 
 
 
 
 
Shares To Calculate EPS Diluted2.7M3.4M7.6M12.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$5.40-$3.50-$1.95-$0.62
 
 
 
 
 
EPS Diluted-$5.40-$3.50-$1.95-$0.62